文献速递先天性心脏病外科

先天性心脏病手术中术中给予镁可降低术后心律失常风险

Lower risk of postoperative arrhythmias in congenital heart surgery following intraoperative administration of magnesium.
PubMed 文献 · J Thorac Cardiovasc Surg · 2018-04-18

该历史性前瞻性观察队列研究采用倾向性评分匹配,评估术中给予镁与先天性心脏病术后心律失常的关系。匹配后,镁 50 mg/kg 与任何心律失常(OR=0.50,P<.001)、交界性异位心动过速(OR=0.56,P=.004)、房性心动过速(OR=0.48,P=.005)、室性心动过速(OR=0.52,P=.04)及房室传导阻滞(OR=0.47,P=.03)的 odds 降低相关;25 mg/kg 与 50 mg/kg 的效应无差异。

要点

  • 术中镁 50 mg/kg 与术后任何心律失常 odds 降低相关(OR=0.50,P<.001)。
  • 镁 50 mg/kg 与交界性异位心动过速、房性心动过速、室性心动过速及房室传导阻滞 odds 降低相关。
  • 镁 25 mg/kg 与 50 mg/kg 对术后心律失常 odds 的降低效应无差异。

核心结论

  • 术中给予镁与所有术后心律失常的 odds 降低相关。
  • 结果未提供证据表明更大剂量镁与更大程度的心律失常风险降低相关。
  • 尽管术中使用了镁,术后心律失常的残余发生率仍高,提出研究新或额外药物的必要性。

研究设计与样本

  • 历史性前瞻性观察队列研究。
  • 采用逻辑回归进行倾向性评分匹配,以建立基于 5 个重要协变量平衡的治疗组相似人群。

主要发现

  • 基于倾向性评分匹配组,镁 50 mg/kg 给药与术后心律失常发生 odds 降低相关:任何心律失常(OR=0.50,P<.001)。
  • 交界性异位心动过速(OR=0.56,P=.004)、加速性交界性心律(OR=0.56,P=.089)、房性心动过速(OR=0.48,P=.005)、室性心动过速(OR=0.52,P=.04)、房室传导阻滞(OR=0.47,P=.03)。
  • 镁 25 mg/kg 与 50 mg/kg 对术后心律失常发生 odds 的降低效应无差异。
  • 多达三分之一的先天性心脏病手术患者发生术后心律失常。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Postoperative arrhythmias are common in children undergoing congenital heart surgery. We evaluated whether intraoperative administration of magnesium was associated with a reduced occurrence of specific postoperative arrhythmias, as has been described previously, or had a broader effect on multiple arrhythmia types, and whether there existed a dose-effect of intraoperative magnesium. METHODS: We used a historical prospective observational cohort study. Propensity score matching using logistic regression was applied to establish similar populations of treatment groups balanced on 5 important covariates. RESULTS: Based on propensity score-matched groups, magnesium 50 mg/kg administration was associated with a reduced odds of occurrence of postoperative arrhythmias: any arrhythmia (odds ratio [OR] = 0.50, P < .001), junctional ectopic tachycardia (OR = 0.56, P = .004), accelerated junctional rhythm (OR = 0.56, P = .089), atrial tachycardia (OR = 0.48, P = .005), ventricular tachycardia (OR = 0.52, P = .04), and atrioventricular block (OR = 0.47, P = .03). The effect of magnesium on reducing the odds of occurrence of postoperative arrhythmias did not differ between 25 mg/kg versus 50 mg/kg. CONCLUSIONS: As many as one third of our patients undergoing congenital heart surgery had postoperative arrhythmias. Use of intraoperative magnesium was associated with a reduction in the odds of occurrence of all postoperative arrhythmias. Our results do not provide evidence that a greater dose of magnesium is associated with greater arrhythmia risk reduction. Despite the intraoperative use of magnesium, there continued to be a high residual incidence of postoperative arrhythmias, raising the question for studying new or additional agents.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. He D, Aggarwal N, Zurakowski D, et al. Lower risk of postoperative arrhythmias in congenital heart surgery following intraoperative administration of magnesium. J Thorac Cardiovasc Surg. 2018. PMID: 29778339. doi:10.1016/j.jtcvs.2018.04.044

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。